“It's like scratching at the door”: Experiences of outpatient buprenorphine low dose initiation among people using fentanyl

This publication has 24 references indexed in Scilit:

• Outpatient Low-Dose Initiation of Buprenorphine for People Using Fentanyl
  JAMA Network Open, 2025
• Mindfulness Training vs Recovery Support for Opioid Use, Craving, and Anxiety During Buprenorphine Treatment
  JAMA Network Open, 2025
• Application of the COM-B model to patient barriers and facilitators of retention in medication treatment for opioid use disorder in rural Northeastern United States: A qualitative study
  SSM - Mental Health, 2022
• Has the treatment gap for opioid use disorder narrowed in the U.S.?: A yearly assessment from 2010 to 2019”
  International Journal of Drug Policy, 2022
• Association of Opioid Agonist Treatment With All-Cause Mortality and Specific Causes of Death Among People With Opioid Dependence
  JAMA Psychiatry, 2021
• The Pharmacology of Buprenorphine Microinduction for Opioid Use Disorder
  Clinical Drug Investigation, 2021
• Fentanyl: Receptor pharmacology, abuse potential, and implications for treatment
  Neuroscience & Biobehavioral Reviews, 2019
• Using the Behaviour Change Wheel to explore potential strategies for minimising harms from non-recreational prescription medicine sharing
  Research in Social and Administrative Pharmacy, 2019
• Relative Efficacy of Mindfulness-Based Relapse Prevention, Standard Relapse Prevention, and Treatment as Usual for Substance Use Disorders
  JAMA Psychiatry, 2014
• Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups
  International Journal for Quality in Health Care, 2007